therosclerosis is an inflammatory disease 1,2 in which macrophages play major roles in all stages of development, from initiation of the fatty streak to processes that lead to plaque rupture and acute coronary events. Macrophages interact with T cells to modulate the evolution of the inflammatory response; importantly, they also help contain the inflammatory process by engulfing and removing apoptotic cells before they disintegrate and release their toxic cellular contents. 3 
See p 3749
Interest in the contributions of apoptosis and cellular proliferation in atherosclerosis development prompted us to examine the role of p53 in the process. We first reported that p53 inactivation led to the development of accelerated atherosclerosis in apolipoprotein E-deficient (apoE Ϫ/Ϫ ) mice. 4 Interestingly, the increased cellularity of atheromas in the absence of p53 was caused primarily by increased cellular proliferation, because we observed no difference in the rate of apoptosis. Recently, we obtained similar data in LDL receptor-deficient (LDLR Ϫ/Ϫ ) mice that received bone marrow transplantation from p53 Ϫ/Ϫ donors, which support the crucial role of bone-marrow-derived cells in the process. 5 A report on the atherogenic effect of transplantation of p53 Ϫ/Ϫ bone marrow to another mutant apoE, apoE*3-Leiden, mouse model further supports the importance of p53 in atherosclerosis development. 6 In contrast, another study showed that induced smooth muscle cell (SMC)-specific overexpression of p53 using recombinant adenovirus leads to atherosclerotic plaque destabilization. 7 The effects of p53 are mediated by different downstream effectors and targets. 8, 9 A Cdk inhibitor, p21
Waf1/Cip1/Sdi1 , is a major mediator of p53 action. 10 -12 p21 effects stress-induced p53-dependent and p53-independent cell proliferation arrest.
In addition, the protein possesses antiapoptotic capabilities, but it may also be involved in monocyte and dendritic cell differentiation. 13, 14 There is substantial evidence that p21 participates in the protective action of p53 on atherosclerosis. Adenoviral vector-mediated delivery of the p21 gene to the vessel wall protected porcine arteries against the development of intimal hyperplasia after balloon injury. 15 Moreover, Condorelli et al 16 showed that overexpression of a mutated form of p21 (that has increased biological activity) by adenovirusmediated gene transfer protected against restenosis in apoE Ϫ/Ϫ mice by reducing SMC proliferation and macrophage infiltration of the lesion. Thus, p21 is generally considered an antiatherogenic molecule and a potential therapeutic gene that can be used to treat or prevent atherosclerosis and postangioplasty restenosis. 15, 16 To investigate the role of p21 in atherosclerosis, we evaluated aortic atherosclerotic lesion development in p21 ϩ/ϩ / apoE Ϫ/Ϫ and p21 Ϫ/Ϫ /apoE Ϫ/Ϫ mice at different ages and under different diet conditions. The involvement of p21 Ϫ/Ϫ macrophages in the process was further explored by bone marrow transplantation experiments. To our surprise, not only does p21 fail to protect against atherosclerosis, but it also actually exhibits a potent proatherogenic effect on lesion development and progression. We examined the gene expression pattern of macrophages by quantifying 23 markers involved in inflammation, phagocytosis, and lipid metabolism. We undertook mechanistic experiments to elucidate the role of p21 in macrophage differentiation and activation. These experiments provide a plausible explanation for the unexpected proatherogenic properties of p21 and reveal an important function of this molecule on macrophage behavior that directly affects the development of atherosclerosis.
Methods

Animals and Diet
p21
Ϫ/Ϫ mice were obtained from Dr Lawrence Donehower and Pumin Zhang at Baylor College of Medicine, 17 and apoE Ϫ/Ϫ mice in C57BL/6J background were purchased from Jackson Laboratories, Bar Harbor, Me. p21 Ϫ/Ϫ mice were backcrossed onto the C57BL/6J background for Ն8 generations. At 6 weeks of age, as specified below, we put some mice on a Western diet (Teklad adjustedcalories Western-type diet: 21% [wt/wt] fat, 0.15% [wt/wt] cholesterol, 19.5% [wt/wt] casein, without sodium cholate). We measured total cholesterol and triglyceride concentrations in plasma at the end of diet feeding by use of enzymatic procedures (Sigma). Fast performance liquid chromatography (FPLC) separation of lipoprotein particles was achieved as described previously. 18 The cholesterol content of the FPLC fractions was measured by use of an enzymatic kit (Sigma). The animal protocol review committee of our institution approved all procedures.
Irradiation and Bone Marrow Transplantation
Fifteen-week-old female apoE Ϫ/Ϫ mice were subjected to 10 Gy total body irradiation to eliminate endogenous bone marrow stem cells and most of the bone marrow-derived cells. Bone marrow cells for repopulation were prepared from apoE Ϫ/Ϫ /p21 Ϫ/Ϫ or apoE Ϫ/Ϫ mice, and transplantation was performed as described previously. 5 After bone marrow transplantation, mice were kept on a regular chow diet. They were killed after 19 weeks, and blood was collected by cardiac puncture into tubes containing EDTA.
Quantitative Morphometry and Immunohistochemistry
We performed cross-sectional analysis of the aortic sinus 19 weeks after bone marrow transplantation. En face study of the atherosclerotic lesion area was performed for all the other time points using complete aortas spanning from the root of the aorta to the iliac bifurcation. We prepared aortas for analysis as described previously. 5 Cryostat sections of the aortic root and aorta were fixed in acetone for 10 minutes and air-dried for at least 30 minutes. After blocking the endogenous peroxidase activity and washing in PBS (pH 7.4), we incubated the sections for 30 minutes with different monoclonal antibodies individually and exposed the sections to peroxidase-or alkaline phosphatase-conjugated secondary antibody for 30 minutes. Primary antibodies used include rat anti-mouse macrophages Mac3 (Santa Cruz), rat anti-mouse vascular cell adhesion molecule (VCAM)-1 (Santa Cruz), rat anti-mouse CD18 (Pharmingen), rabbit anti-SMC-specific epitope actin (Spring Bioscience), or rabbit anti-mouse scavenger receptor type B-I (SR-BI) (Novus Biologicals). We detected proliferating and apoptotic cells using a bromodeoxyuridine (BrdU) staining kit (Zymed Laboratories) and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) (Roche), respectively, as described. 5 We visualized collagen by use of trichrome staining and elastic fibers using Verhoeff's-van Gieson staining.
Phagocytosis Activity of Isolated Peritoneal Macrophages
Peritoneal macrophages were activated with intraperitoneal injection of 1 mL of 3% aged Brewer's thioglycolate (Difco Laboratories) 3 days before collection. We used 2-m Nile red fluorescent latex FluoSpheres (F-8825, Molecular Probes) for the phagocytosis experiment. We washed the beads twice with Tris buffer, pH 9.0, and coated them with BSA by incubation with 5 mg/mL solution of BSA in the same Tris buffer for 2 hours at 37°C; we then washed them twice with PBS containing 0.1% gelatin and once with RPMI before resuspending them in RPMI containing 10% heat-inactivated FBS. For the phagocytosis experiment, we added the BSA-coated beads to the plated cell suspension at a 100:1 ratio of microspheres to cells and incubated the mixture at 37°C for 90 minutes. We then removed the free microspheres and other unattached cells by washing with RPMI, washed the cells with PBS, then fixed and processed them for immunohistochemistry.
To examine the macrophage-mediated phagocytosis of apoptotic thymocytes, we prepared mouse thymocytes as described by Chang et al. 19 Briefly, we added 10ϫ10 6 CellTracker-labeled dexamethasone-treated thymocytes to the macrophage monolayers and incubated them for 80 minutes at 37°C. Wells were washed 5 times with ice-cold PBS and treated with 0.25% trypsin/0.02% EDTA for 20 minutes at 22°C to remove uninternalized thymocytes. We fixed the cells with 4% paraformaldehyde in PBS and evaluated the presence of internalized apoptotic thymocytes in the macrophage preparation by microscopic observation.
Real-Time Quantitative RT-PCR and Western Blotting
Total RNA was extracted from macrophages by use of Absolutely RNA reverse transcription-polymerase chain reaction (RT-PCR) Miniprep Kit (Stratagene) with an additional RNase-free DNase digest of genomic DNA. Total RNA was reverse-transcribed into cDNA by use of Superscript II reverse transcriptase (Invitrogen) and oligo (dT) primers in a total volume of 80 L. Reaction proceeded at 42°C for 50 minutes and was terminated with a denaturation step at 70°C for 15 minutes. Reverse-transcribed RNA was primed with oligonucleotides specific for the following genes: SR-B1 (5Ј-CAGTAGTTCTGCCGTTGCTG-3Ј and 5Ј-TGAATGGCCTCC-TTATCCTG-3Ј), LDLR (5Ј-GAAAAGGCTACTGGCTGTGC-3Ј and 5Ј-CCAGGACCCGGTCAGTAGTA-3Ј), ABCA1 (5Ј-TT-GTTCCAAAGAGCCATGTG-3Ј and 5Ј-GCTTGGAATGAGGG-CCAATG-3Ј), CD36 (5Ј-CAGCAAGGCCAGATATCACA-3Ј and 5Ј-TGCAGCTGAGCAGAAAGAGA-3Ј), MSR-A (5Ј-ATGAT-CGCTGGGATATACGG-3Ј and 5Ј-ACCCCAGCATCTTCT-GAATG-3Ј), ␤-actin (5Ј-GACGGCCAGGTCATCACTAT-3Ј and 5Ј-CTTCTGCATCCTGTCAGCAA-3Ј), LDL receptor-related protein (LRP1) (5Ј-TGTTCTCGAATGGGTTGTCA-3Ј and 5Ј-CCATCTGTGTTGGTGCAAAG-3Ј), PSR1 (5Ј-TCTGCTCAA-TGCACAAGAGG-3Ј and 5Ј-TGGGCACCTTGTAGTCTTCC-3Ј), p16 (5Ј-TCAACTACGGTGCAGATTCG-3Ј and 5Ј-TCGCACG-ATGTCTTGATGTC-3Ј), p21 (5Ј-GTACTTCCTCTGCCCT-GCTG-3Ј and 5Ј-TCTGCGCTTGGAGTGATAGA-3Ј), p27 (5Ј-AGAACTAACCCGGGACTTGG-3Ј and 5Ј-CGGGGGCCT-GTAGTAGAACT-3Ј), p53 (5Ј-TTTTGAAGGCCCAAGTGA-AG-3Ј and 5Ј-TGAGGGGAGGAGAGTACGTG-3Ј), p57 (5Ј-CCAGCGATACCTTCCCAGT-3Ј and 5Ј-CCTGCTGGAAGT-TGAAGTCC-3Ј), pRB (5Ј-GCCAGGCTTGAGTTTGAAGA-3Ј and 5Ј-AGATGCCCCAGAGTTCCTTC-3Ј), peroxisome proliferatoractivated receptor-␥ (5Ј-CTCCTGTTGACCCAGAGCAT-3Ј and 5Ј-AATGCGAGTGGTCTTCCATC-3Ј), interleukin (IL)-1␣ (5Ј-TCGGGAGGAGACGACTCTAA-3Ј and 5Ј-GTGCACCCGACTT-TGTTCTT-3Ј), tumor necrosis factor (TNF)-␣ (5Ј-CGGACTCC-GCAAAGTCTAAG-3Ј and 5Ј-CGTCAGCCGATTTGCTATCT-3Ј), macrophage inflammatory protein (MIP)-1 (5Ј-AGGCTACA-GGGCCTGTTGT-3Ј and 5Ј-GGGTTGAGGCAAACTTCTTG-3Ј), MIP-2 (5Ј-AGTGAACTGCGCTGTCAATG-3Ј and 5Ј-TTCAG-GGTCAAGGCAAACTT-3Ј), FcRIIB (5Ј-CCCTGGGAACTCTT-CTACCC-3Ј and 5Ј-CAGCAGCCAGTCAGAAATCA-3Ј), transforming growth factor (TGF)-␤ (5Ј-TGCGCTTGCAGAG-ATTAAAA-3Ј and 5Ј-GCTGAATCGAAAGCCCTGTA-3Ј), MCP1 (5Ј-CCCACTCACCTGCTGCTACT-3Ј and 5Ј-ATTTGGTTTCCG-ATCCAGGTT-3Ј), and IL-1␤ (5Ј-CTCTGCTTGTGAGGTG-CTGA-3Ј and 5Ј-GGGCCTCAAAGGAAAGAATC-3Ј). The quantitative PCR reaction was performed in 20 L with 2 L cDNA, 10 L 2ϫ SYBR Green master mix (Stratagene), 0.3 L ROX (internal dye control), and 0.5 pmol sense and antisense primers. The quantitative PCR reactions were performed in optical 96-well strips with optical caps by use of the MX3000p Multiplex quantitative PCR system (Stratagene). We used the same thermal profile conditions for all primer sets. The reaction conditions were as follows: 50°C for 2 minutes, 95°C for 10 minutes, and then 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. Emitted fluorescence for each reaction was measured 3 times during the annealing/extension phase, and amplification plots were analyzed by use of MX3000p software version 3.0 (Stratagene). Potential genomic DNA contamination was controlled by use of some intron-encompassing primers. Samples were normalized (as indicated) on the basis of their transferrin or ␤-actin content. For Western blot analysis, we extracted protein from cultured peritoneal macrophages by use of M-PER protein extraction reagent (Pierce) supplemented by protease inhibitor cocktail (Complets, Roche). The extracts were fractionated on 4% to 15% gradient SDS-PAGE, and the separated proteins were transferred to a polyvinylidine difluoride membrane (Bio-Rad). We incubated the membrane with the following primary antibodies: rabbit anti-mouse SR-BI (Novus Biologicals), goat anti-mouse SR-A (Santa Cruz Biotechnology), or rabbit anti-mouse p27 (Neomarkers, LabVision Corp), followed by horseradish peroxidase-conjugated secondary antibody. The immunoreactive bands were detected with enhanced chemiluminescence (Pierce). Actin was used as an internal control.
Statistical Analysis
We used the t test routinely except when value distribution failed the normality test of ANOVA, in which case we used the Mann-Whitney rank-sum test as specified (SigmaStat, Jandel Scientific). Values are expressed as meanϮSD. The level of PϽ0.05 was set to be significant.
Results p21 Inactivation Protects Against Atherosclerosis in apoE ؊/؊ Mice
We assessed the effect of p21 inactivation in apoE Ϫ/Ϫ mice maintained on a regular chow first at an early stage (20 weeks of age) and then at an advanced stage (63 weeks, or Ϸ14 months) of atherosclerosis development. Measurement of lesions at this early time by use of computer-assisted histo- logical cross-sectional analysis revealed that the absence of p21 reduced atherosclerotic lesion size by 53% (45 554Ϯ26 356 versus 97 386Ϯ30 798 m 2 , PϽ0.05, male mice, Figure 1A ). We next evaluated atherosclerosis at a much more advanced stage at 14 months of age by use of an en face method, which computes the total lesion area in the entire aorta, and found again a highly significant protective effect of absence of p21; there was a 32% reduction in lesion size in p21 Figure 1B] . To study the role of p21 in the setting of markedly accelerated atherosclerosis, we fed 6-week-old male and female p21 Ϫ/Ϫ /apoE Ϫ/Ϫ and p21 ϩ/ϩ / apoE Ϫ/Ϫ mice an atherogenic diet (western diet, see Methods) for 15 weeks and then compared their aortic lesion areas by quantitative en face analysis. Again, the presence of p21 expression was associated a significant proatherogenic effect on the aggressive atherosclerosis occurring in the aorta of apoE Ϫ/Ϫ mice under these conditions ( Figure 1C ). Comparing male apoE Ϫ/Ϫ mice that expressed p21 with male apoE
mice lacking p21, we found that the lesion area was significantly larger (39%) (PϽ0.05); lesion area was also larger (31%) in female apoE Ϫ/Ϫ mice expressing p21 compared with female apoE Ϫ/Ϫ mice, although the difference did not reach statistical significance (Pϭ0.07). The total blood counts (white blood cells, red blood cells, and platelets) were similar in p21 Ϫ/Ϫ /apoE Ϫ/Ϫ and p21 ϩ/ϩ /apoE Ϫ/Ϫ mice (data not shown), as were plasma cholesterol and triglyceride concentration and lipoprotein profiles, whether the mice were fed chow diet ( Figure 1D ) or western diet (data not shown).
Inspection of the luminal surface of the aorta revealed much larger lesions in p21 ϩ/ϩ /apoE Ϫ/Ϫ (aorta on the left, Figure 2A ) compared with those of p21 Ϫ/Ϫ /apoE Ϫ/Ϫ mice (aorta on the right, Figure 2A ). Analysis of trichrome-stained atherosclerotic lesion ( Figure 2B ) showed smaller lesions in p21 Ϫ/Ϫ /apoE Ϫ/Ϫ mice (lefts) compared with p21 ϩ/ϩ /apoE Ϫ/Ϫ mice (rights), amounting to a 52% and a 43% reduction in the valve (uppers) and sinus areas (middles), respectively. Examination at higher magnification of similar-sized lesions (Figure 2B , lowers) showed a thicker and better-formed fibrous cap (arrowhead, SMC stained red) in the p21 Ϫ/Ϫ /apoE Ϫ/Ϫ mice (left) compared with apoE Ϫ/Ϫ mice (right), indicating the presence of more stable-looking lesions in mice lacking p21.
Lesions Associated With Global p21 Inactivation Display Increased Apoptosis, Reduced Vascular Cell Adhesion Molecule-1 Immunostaining, but No Change in Cellular Proliferation
Because p21 is a known regulator of cellular proliferation and apoptosis, 17, 20 we investigated how its absence affects these 2 processes in the atherosclerotic lesion. We determined the frequency and location of apoptotic cells in atherosclerotic lesions in 20-week-old p21
As determined by an in situ DNA end-extension technique, apoptotic cells appeared to be randomly distributed in both genotypes. The frequency of apoptotic cells was significantly (182%) higher in the lesions of apoE Ϫ/Ϫ mice lacking p21 compared with those expressing p21 (2.02Ϯ0.30% versus 1.11Ϯ0.19%, PϽ0.005, Figure 3A) .
The increased rate of apoptosis in the absence of p21 corroborates its antiapoptotic activities reported by others. 20 The cellular proliferation rate as measured by the rate of BrdU incorporation into cells in the atheromatous lesions was Figure 3B ). Figure 3D) ; the reduced inflammation in p21 Ϫ/Ϫ /apoE Ϫ/Ϫ mice may contribute to retardation of the atherosclerotic process in these animals. 21 who showed elegantly that self-renewal of stem cells was impaired in serially transplanted bone marrow from p21 Ϫ/Ϫ mice, which eventually died of hematopoietic failure. In the mice that survived 19 weeks after transplantation, we found that compared with mice that received p21 ϩ/ϩ bone marrow, the absence of p21 expression in the donor cells was associated with a 32% reduction in atherosclerosis in the recipient apoE Ϫ/Ϫ mice (PϽ0.01) (Figure 4, A and B) . Cross-sectional analysis of oil red O-stained frozen sections showed significant reduction in lesion area involving the aortic valve region ( Figure 4B, transplants ( Figure 4C and Table 2 ). Immunostaining of ␤-actin revealed a more prominent fibrous cap in lesions from mice that had received p21 Ϫ/Ϫ marrow ( Figure 4D, left) . Moreover, we observed the presence of buried fibrous caps in some lesions, indicative of previous plaque ruptures, 22 a finding associated with accelerating lesion growth through repeated erosions. 23 Quantification of buried caps among lesions revealed a lower frequency of these indictors of ruptured plaques in the absence of p21 ( Figure 4E and Table  2 ). The difference in frequencies suggests that approximately Ϫ/Ϫ marrow presented higher rate of apoptosis compared with those in control mice (left histogram). Cell typing of apoptotic cells reveals a significant difference involving macrophage (Ϸ3 times higher, PϽ0.05, after transplantation of p21 Ϫ/Ϫ bone marrow, right histogram) but no significant difference between apoptotic SMCs between groups receiving p21 Ϫ/Ϫ or p21 ϩ/ϩ bone marrow cells.
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half of these events might have been averted in p21 Ϫ/Ϫ / apoE Ϫ/Ϫ mice compared with p21 ϩ/ϩ /apoE Ϫ/Ϫ (frequencies of 20% versus 43%, respectively, Table 2 ). We found an increased rate of apoptosis ( Figure 4F ) in the lesions of mice transplanted with p21 Ϫ/Ϫ /apoE Ϫ/Ϫ bone marrow compared with those transplanted with p21 ϩ/ϩ /apoE Ϫ/Ϫ marrow ( Figure  4F , left histogram, and Table 2 ). Cell typing of apoptotic cells showed a 3-fold increase in apoptotic macrophages in lesions of mice that received p21 Ϫ/Ϫ /apoE Ϫ/Ϫ bone marrow compared with those that received p21 ϩ/ϩ /apoE Ϫ/Ϫ marrow ( Figure 4F , right histogram, and Table 2 ). Although the majority of the Mac3-immunoreactive apoptotic cells appear to be apoptotic macrophages, we cannot exclude the possibility that some of the TUNELϩ material represents apoptotic fragments (from other cell types) engulfed by the macrophages. SMCs were not significantly affected by p21 status ( Table 2 ). The absence of p21 and its associated antiapoptotic function in the lesional macrophages may account for their higher rate of apoptosis in mice transplanted with p21 Ϫ/Ϫ /apoE Ϫ/Ϫ bone marrow.
Macrophages Lacking p21 Display Increased Phagocytic Activity
We studied the role of p21 in modulating the phagocytic avidity of isolated macrophages, a property that influences atherosclerosis development. 3 Macrophages isolated from mice lacking p21 ingested approximately 3 times more latex microsphere beads when incubated with them in vitro (PϽ0.005) compared with macrophages from mice that expressed p21 ( Figure 5A ). To determine whether the increased phagocytic activity toward an artificial substrate such as latex beads is also seen with a more pathophysiologically relevant substrate, we evaluated the effect of p21 expression on the avidity with which the macrophages ingested apoptotic thymocytes, an antiinflammatory function. We found that the number of FITC-positive apoptotic cells internalized per macrophage per unit time was 2-fold higher in macrophages lacking p21 compared with those that expressed the protein (2.48Ϯ0.90 versus 1.27Ϯ0.25, Pϭ0.01, Figure 5B ).
Gene Expression Profile of Thioglycolate-Elicited Peritoneal Macrophages
Using quantitative real-time RT-PCR, we studied the expression level of 23 markers by macrophages that expressed p21 and those that did not. We concentrated on genes that were relevant to atherosclerosis development and progression. The transcripts studied include the following: CD36, MSR-A, SR-BI, LDLR, LRP1, phosphatidyl serine receptor (PSR), ABCA1, FcR␥II, TNF-␣, macrophage inflammatory proteins 1 and 2 (MIP1, MIP2), IL-1␣, IL-1␤, TGF-␤, MCP-1, peroxisome proliferator-activated receptor-␥ a, p16, p27, p57, pRB, and p53 in addition to p21. Genes that showed a difference in expression level involved primarily those that encode inflammation-related molecules. Absence of p21 in macrophages was characterized by significantly reduced expression of the transcripts for the following proinflammatory genes: MIP-1, MIP-2, and IL-1␣, and a tendency toward lower expression of IL-1␤ ( Figure 6A ). MIPs display mostly proinflammatory actions in vivo and in vitro. 24 MIP-1 and 2, both downregulated in the absence of p21, are involved in the recruitment of leukocytes to sites of infection and the activation of these cells as an important component of the local inflammatory response. 25 IL-1␣ acts through its precursor form as an activator of proinflammatory genes via nuclear factor-B. 26 The role of IL-1␤ in atherosclerosis has been studied recently in apoE Ϫ/Ϫ mice. 27 IL-1␤ deficiency was shown to protect against atherosclerosis in this mouse model. In contrast to these inflammation-related gene transcripts, we found that macrophages lacking p21 expressed significantly higher amounts of LRP1 and SR-BI ( Figure 6 , B and C). Both receptors are involved in phagocytosis and in maintaining a protective balance of lipids/lipoproteins and the integrity of the vascular wall. 28 -30 We next examined the expression by the macrophages of other cell cycle genes, including p16, p27, p57, pRB, and p53 ( Figure 6D ). The expression of p27 and p57, the other 2 members of the Cip/Kip family (like p21), was not different between p21 Ϫ/Ϫ and p21 ϩ/ϩ macrophages. In the absence of p21, transcripts for p16, pRB, and p53 were significantly upregulated, being the highest for p16 (PϽ0.0001) and to a lesser extent for pRB and p53 (PϽ0.05). Values are expressed as meanϮSD. *PϽ0.05.
The prominent upregulation of p16 suggests a compensatory process involving these cell cycle proteins. Unlike p21, which affects the activity of a wide range of cyclin-dependent kinases (CDKs), p16 is a specific potent inhibitor of CDK4. When present at these increased levels, p16 is capable of displacing the Cip/Kip family members (p21, p27, p57) from interacting with CDK4 -cyclin D. 31, 32 Consequently, more Cip/Kips would be available to interact with and inhibit CDK2, which action by itself is capable of inhibiting the progression of the cell cycle. We further analyzed the expression of the macrophage cell surface receptors, macrophage scavenger receptor A (MSR-A) and SR-BI, by Western blotting (Figure 7 ). These receptors are known to be involved in atherosclerosis development in mice. 28, 29 Although the MSR-A level did not differ between cells with and without p21 ( Figure 7A ), SR-BI protein expression was Ͼ3 times higher in macrophages lacking p21 ( Figure 7B ). This finding corroborates the higher level of SR-BI in the aortic lesions of p21 Ϫ/Ϫ /apoE Ϫ/Ϫ mice compared with p21 ϩ/ϩ /apoE Ϫ/Ϫ mice as determined by immunohistochemical staining ( Figure 7C ).
Discussion
p21 is a major target of p53, and p53-dependent cell cycle arrest is thought to be mediated primarily by p21. A major rationale for us to investigate p21 in atherosclerosis was that fact that we and others found that p53 Ϫ/Ϫ mice exhibit accelerated atherosclerosis in different genetic and dietary models, 4 -6 implicating p53 as an antiatherogenic molecule. The overall proatherogenic action of p21 revealed by this study was totally unexpected, because p21 had been shown to have potential antiatherogenic effects in several models and was in fact cited as a promising therapeutic gene for the treatment of atherosclerosis. 15, 16 Indeed, we showed here that global p21 inactivation protects against atherosclerosis development and promotes a stable phenotype in the presence of increased apoptosis but no change in cellular proliferation. Furthermore, transplantation of p21 Ϫ/Ϫ bone marrow cells reproduced the protective effect of global p21 inactivation in terms of atherosclerosis progression and apoptosis rate, suggesting that the absence of p21 function in the macrophages that infiltrate the atherosclerotic lesions was important to the protection. This conclusion was reinforced by the fact that the increased rate of apoptosis in the lesion after bone marrow transplantation affected exclusively macrophages derived from p21 Ϫ/Ϫ donors. The p21 Ϫ/Ϫ macrophages exhibit other important properties, including a higher phagocytotic capacity, reduced expression of proinflammatory cytokines such as IL-1␤ and MIP-1 and 2, but increased expression of putative protective genes such as LRP1 and SR-BI. Finally, p16 expression is upregulated as a compensatory response to the loss of p21.
Why Does the Absence of a CKI (p21) Not Translate Into Proliferation Signals?
We can envision the scenario outlined below. Cell cycle progression from G 1 to S is governed by several classes of CDKs whose activities are in turn regulated by 2 families of CDK inhibitors (CKIs). The INK4 proteins, including p15, p16, p18, and p19, bind only to and inhibit CDK4 and CDK6 (D-cyclin-dependent kinases) but do not bind to other CDKs. The Cip/Kip family proteins (p21, p27, p57) affect the activities of cyclin D-, E-, and A-dependent kinases. They are potent inhibitors of cyclin E-and A-dependent CDK2 but act as positive regulators of cyclin D-dependent kinases.
The generally accepted view is that cyclin D-dependent kinases initiate Rb phosphorylation in mid-G 1 phase, after which cyclin E-CDK2 becomes active and completes this process by phosphorylating Rb on additional sites, annulling its ability to repress E2F family members and activating genes required for entry into S phase (Figure 8 ). Cyclin Aand B-dependent CDKs activated later during the cell cycle maintain Rb in a hyperphosphorylated form until the cell exits mitosis and Rb is returned to a hypophosphorylated state in the next G 1 phase.
Under normal conditions initially, the inhibitory effects of Rb and the Cip/Kips on cell proliferation are overcome through a mitogen-dependent program mediated by the D cyclins. In response to mitogenic stimulation, D cyclins accumulate and participate in 2 functions: in one, cyclin D-dependent kinases phosphorylate Rb; in the other, cyclin D-CDK complexes bind to and sequester Cip/Kip proteins. 33, 34 Sequestration of Cip/Kip proteins lowers the inhibitory threshold and facilitates activation of the cyclin E-CDK2 complex and further phosphorylation of Rb. This sequential phosphorylation of Rb ultimately heralds entry into S phase. 35 The decision on how to proceed during the cell cycle is somehow affected by the distribution balance of Cip/Kip family members, whether they are sequestered by the CDK4-cyclin D or they assemble with CDK2-cyclin E inducing their enzymatic inhibition (Figure 8 ).
The expression of p16 (INK4) increases 3-fold in macrophages that lack p21. Increased amounts of p16 protein would compete more effectively with Cip/Kip (p27, p57) proteins for CDK4 binding 31 and alter the distribution of CDK4 in favor of CDK4-p16 complexes (leading to inhibition of CDK4) and thereby induce the release of the sequestered Cip/Kip proteins. 31, 32 p16-induced redistribution of p27 and p57 from CDK4 -cyclin D to CDK2-cyclin E complexes increases the amount of available p27 and p57 that can bind to CDK2 (Figure 8 ). Under these conditions, p27 and p57 contribute more efficiently to the inhibition of CDK2-cyclin E without a need for increased p27 or p57 synthesis. In this way, the absence of p21 is accompanied by a compensatory upregulation of p16, leading indirectly to normalized inhibition of CDK2-cyclin E by the remaining members of the Cip/Kip family.
In contrast to the absence of p21, p53 deficiency leads to an increased rate of cellular proliferation and accelerated atherosclerosis 4 ; probably, cell cycle control is receiving different stimuli in this situation. In the absence of p53, p21 loses one of its major inducers; meanwhile, the balance of other cell cycle genes is not clearly established. However, one possibility remains that in p53 Ϫ/Ϫ cells and, in the absence of any compensatory change, the levels of p21 (and the Cip/Kip family members overall) would not reach the threshold of effective interaction with CDK2 necessary for the inhibition of its activity, and the cell cycle transition signals would be to go forward. Similar consequences (low effective inhibitory Cip/Kip proteins) might occur in the absence of p27. Indeed, inactivation of p27 in apoE Ϫ/Ϫ mice was shown to lead to accelerated atherosclerosis, 36 with the p27 Ϫ/Ϫ /apoE Ϫ/Ϫ mice exhibiting many of the phenotypic effects, eg, increased cellular proliferation, that we previously reported for p53 Ϫ/Ϫ / apoE Ϫ/Ϫ mice. 4 p21 and p53 seem to exhibit contrasting roles in the regulation of apoptosis. During atherosclerosis development, apoptosis occurs in both p53-dependent and p53-independent ways. 4 There is mounting evidence that p21 may be an inhibitor of p53-dependent apoptosis. 20 It is important to note that p21 itself is under the control of different signals, such as TGF-␤, TNF-␣, histone deacetylase inhibitors, interferon-␥, and other factors that may simultaneously induce p53-independent apoptosis and p53-independent transactivation of p21. 20 p21 may block apoptosis by interacting with proapoptotic molecules such as procaspase-3, 37 caspase-8, and the kinase apoptosis signal-regulating kinase 1 (ASK1). 13 In the absence of p21, and without the inhibitory influence of p21, apoptosis might be induced through different pathways, which may involve p53 but also many other factors, as mentioned earlier. One mechanism by which p21 might facilitate atherosclerosis progression is by blocking the apoptosis of inflammatory cells. Apoptosis of macrophages itself may retard the accumulation of lipids and the generation of foam cells. Loss of p21 appears to promote apoptosis, limit inflammation in the lesion, and slow down lesion growth in atherosclerosis. Effective clearance of apoptotic cells is an important step in interrupting the inflammatory process and preventing the secondary necrosis that ensues. 20, 38 Efficient phagocytic removal of apoptotic cells by macrophages is a plausible mechanism by which absence of p21 exerts its antiinflammatory effects, because p21 Ϫ/Ϫ macrophages are characterized by enhanced phagocytic capability. The upregulated SR-BI and LRP1 expression in p21 Ϫ/Ϫ macrophages may mediate the increased phagocytic activity observed. Both receptors have been found to protect against atherosclerosis, 39 -42 and both have been implicated in phagocytosis. 28 -30 For example, SR-BI was shown to recognize apoptotic cells directly; suppression of SR-BI expression by use of antisense oligonucleotides decreases the binding of apoptotic cells by more than 40%. 29 LRP1 was found to trigger phagocytosis through its cytoplasmic domain, and mutations in this domain decreased phagocytosis by 70%. 30 These studies and our Ϫ/Ϫ /apoE Ϫ/Ϫ and p21 ϩ/ϩ /apoE Ϫ/Ϫ mice. MSR-A (A) and SR-BI (B) protein levels were assessed using actin as a standard. Samples were analyzed from individual mice. C, SR-BI expression in aortic atherosclerotic lesions was determined by immunostaining in aortic sections taken from p21 Ϫ/Ϫ /apoE Ϫ/Ϫ mice (left) and those from p21 ϩ/ϩ /apoE Ϫ/Ϫ mice (right).
current observations provide an important link between atherosclerosis and macrophage phagocytic activity. In addition to their role in phagocytosis, SR-BI and LRP1 are involved in maintaining the proper balance of lipids/lipoprotein 39, 40 and in protecting the integrity of the vascular wall by controlling platelet-derived growth factor-dependent signaling pathways and other mechanisms that mediate SMC proliferation and migration. 41 In addition to promoting the resolution of inflammation by avidly phagocytosing apoptotic cells, p21 Ϫ/Ϫ macrophages also reduce their production of proinflammatory cytokines. The diminished VCAM-1 immunostaining in p21 Ϫ/Ϫ /apoE Ϫ/Ϫ mice is an in vivo manifestation of the reduced inflammatory state in mice lacking p21. The proinflammatory function of p21 corroborates the observation of Chang et al 43 that p21 overexpression led to the induction of a panel of gene products, including the proinflammatory protein SAA, that accompany various inflammatory disorders, such as osteoarthritis, rheumatoid arthritis, and atherosclerosis. 44 We conclude that, unexpectedly, in contrast to the negative growth suppressors p53 and p27, p21 is a proatherogenic molecule. Inactivation of p21 appears to protect against atherosclerosis, slowing down lesion growth and promoting lesion stability through multiple mechanisms: (1) stimulating apoptosis of immune cells, facilitating inflammation resolution, and retarding lesion growth; (2) limiting the production of proinflammatory cytokines and protecting against cytotoxic inflammatory response; and (3) upregulating the phagocytic activity of macrophages, facilitating the safe clearance of apoptotic cells, and preventing secondary necrosis and the uncontrolled release of toxic contents, culminating in a more stable lesion phenotype. Therapies that target p21 for inactivation in the appropriate context might offer protection against atherosclerosis. 
